SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
1-Year Return 17.43%
This Quarter Return
+35.99%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.46B
AUM Growth
+$403M
Cap. Flow
+$127M
Cap. Flow %
8.68%
Top 10 Hldgs %
62.29%
Holding
88
New
21
Increased
19
Reduced
9
Closed
13

Top Buys

1
AKUS
Akouos, Inc. Common Stock
AKUS
$34.1M
2
GILD icon
Gilead Sciences
GILD
$31M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$26.9M
4
LLY icon
Eli Lilly
LLY
$24.4M
5
ABBV icon
AbbVie
ABBV
$19.8M

Top Sells

1
ALXN
Alexion Pharmaceuticals Inc
ALXN
$27.6M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
$21.8M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
$20.4M
4
BIIB icon
Biogen
BIIB
$16.7M
5
MRUS icon
Merus
MRUS
$10.5M

Sector Composition

1 Healthcare 98.35%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NCNA
26
NuCana
NCNA
$5.46M
$12.3M 0.77%
453
– –
SUPN icon
27
Supernus Pharmaceuticals
SUPN
$2.55B
$11.4M 0.72%
+478,329
New +$11.4M
ZYME icon
28
Zymeworks
ZYME
$1.07B
$10.8M 0.68%
299,734
+249,745
+500% +$9.01M
MYOK
29
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.8M 0.68%
111,810
-63,308
-36% -$6.12M
MIRM icon
30
Mirum Pharmaceuticals
MIRM
$3.73B
$10.5M 0.66%
541,701
+123,112
+29% +$2.4M
KURA icon
31
Kura Oncology
KURA
$706M
$9.96M 0.63%
+610,979
New +$9.96M
AKBA icon
32
Akebia Therapeutics
AKBA
$801M
$9.26M 0.58%
+681,892
New +$9.26M
CHMA
33
DELISTED
Chiasma, Inc. Common Stock
CHMA
$8.77M 0.55%
1,630,221
– –
KDMN
34
DELISTED
Kadmon Holdings, Inc.
KDMN
$7.84M 0.49%
1,530,864
+4,686
+0.3% +$24K
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$10.9B
$7.76M 0.49%
62,897
-177,149
-74% -$21.8M
BPMC
36
DELISTED
Blueprint Medicines
BPMC
$7.4M 0.47%
94,891
+31,791
+50% +$2.48M
AXSM icon
37
Axsome Therapeutics
AXSM
$6.21B
$7.16M 0.45%
86,978
+13,815
+19% +$1.14M
LQDA icon
38
Liquidia Corp
LQDA
$2.48B
$6.74M 0.42%
+800,000
New +$6.74M
BCRX icon
39
BioCryst Pharmaceuticals
BCRX
$1.74B
$6.47M 0.41%
1,357,848
+542,158
+66% +$2.58M
AGTC
40
DELISTED
Applied Genetic Technologies Corporation
AGTC
$6.35M 0.4%
1,145,254
+82,639
+8% +$458K
CNST
41
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$6.22M 0.39%
+207,087
New +$6.22M
ITCI
42
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.21M 0.39%
241,908
+189,903
+365% +$4.87M
OTIC
43
DELISTED
Otonomy, Inc.
OTIC
$5.98M 0.38%
1,651,411
+135,782
+9% +$492K
PTGX icon
44
Protagonist Therapeutics
PTGX
$3.71B
$5.76M 0.36%
+326,064
New +$5.76M
CCXI
45
DELISTED
ChemoCentryx, Inc.
CCXI
$5.58M 0.35%
96,916
+30,221
+45% +$1.74M
CALA
46
DELISTED
Calithera Biosciences, Inc
CALA
$5.49M 0.35%
52,020
+11,070
+27% +$1.17M
KALA icon
47
KALA BIO
KALA
$102M
$5.33M 0.34%
10,143
-12,170
-55% -$6.39M
QTTB icon
48
Q32 Bio
QTTB
$20.2M
$5.23M 0.33%
19,143
+6,328
+49% +$1.73M
CYTK icon
49
Cytokinetics
CYTK
$5.95B
$3.78M 0.24%
+160,217
New +$3.78M
ETTX
50
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$3.49M 0.22%
1,180,178
– –
1
2
3 4